A L Jarvenpaa

Learn More
We assessed postnatal growth, neurodevelopmental outcome, and occurrence of respiratory illnesses in 46 infants of very low birth weight who were enrolled in a randomized, controlled, bicenter clinical trial of human surfactant treatment for respiratory distress syndrome. No long-term adverse effects of human surfactant treatment were detected between(More)
We performed a randomized, prospective clinical trial comparing intratracheal administration of human surfactant with conventional treatment with intermittent mandatory mechanical ventilation alone for treatment of severe respiratory distress syndrome in preterm infants of less than 30 weeks gestation. Twenty-two infants (mean gestational age 27.0 weeks,(More)
We undertook a randomized, controlled trial to determine whether human surfactant administered endotracheally at birth to very premature infants (gestational age, 24 to 29 weeks) would prevent the respiratory distress syndrome or reduce its severity. Thirty-one treated infants (birth weight, 938 +/- 286 g) were compared in a blinded fashion with 29 control(More)
Myoinositol (INO) may potentiate hormone-induced lung maturation & increase surfactant in lung damage (Ped Res 17, 378A,-83; Life Sci 31, 175,-82). Serum INO is high in RDS at birth. INO decreases after birth, in part because the diet may contain only little INO. In the present randomized double-blind trial involving 22 RDS cases (BW <2000g), we studied the(More)
INTRODUCTION Preterm birth at very low birth weight (VLBW; <1500g) is associated with cardiometabolic risk factors and reduced bone mineral density (BMD) in the adult offspring. Pre-eclampsia (PE) is a frequent cause of preterm birth and is also associated with cardiometabolic risk factors in the offspring. Whether it is associated with BMD is not known. (More)
The effect of dietary protein quantity and quality on the excretion of creatinine in preterm and term neonatal infants has been investigated. Whey protein predominant formulas result in increased creatinine excretion as compared with either casein protein predominant formulas or with pooled human milk in preterm infants (p less than 0.001 by ANOVA). The(More)
  • 1